• Hello, this board in now turned off and no new posting.
    Please REGISTER at Anabolic Steroid Forums, and become a member of our NEW community!
  • Check Out IronMag Labs® KSM-66 Max - Recovery and Anabolic Growth Complex

Cla

zenith

Registered
Joined
Jan 27, 2004
Messages
101
Reaction score
0
Points
0
Age
38
Does it burn great deal of fat and build muscle.

Is cla anygood and will it help build muscle.

Im reading claims that it helps protien and nitrogen and strips body fat while building muscle. its allso ment to help prevent muscle breakdown ?
 
CLA does not burn fat or help build muscle.
 
Studies have shown that CLA helps with fat loss.

Don't have links though...seems like it was posted here before though.
 
I took CLA for the first time during my current cutting cycle. I obviously made a lot of changes, not just CLA, but I have actually gained LBM while losing 8 pounds, and all my lifts have gone up. I think CLA is legit, I think big doses do a lot more (but also give you deadly gas), and it's relatively cheap.

There are a lot of studies...done on pigs (no joke). The researchers fed the pigs grain with CLA added for two months prior to butchering, and found less fat and more meat (less marbling), which was good for the farmers, so farmers began adding it to feeder pig food.

There may be other studies done on humans, but I'm not positive. Anyone else know?
 
http://www.sciencedaily.com/releases/2003/01/030129080354.htm

Supplementing the diet with a certain fatty acid may lead to better weight control and disease management in diabetics, a new study suggests.

Diabetics who added an essential fatty acid called conjugated linoleic acid (CLA) to their diets had lower body mass as well as lower blood sugar levels by the end of the eight-week study. Hyperglycemia, or high blood sugar, is a hallmark of diabetes.

Researchers also found that higher levels of this fatty acid in the bloodstream meant lower levels of leptin, a hormone thought to regulate fat levels. Scientists think that high leptin levels may play a role in obesity, one of the biggest risk factors for adult-onset diabetes.
 
yet again

CLA INHIBITS PROSTATE CANCER GROWTH AND METASTASIS

Conjugated linoleic acid (CLA) has been shown in physiological concentrations (i.e. low doses) to inhibit proliferation of human tumor cell lines including glioblastoma, melanoma, colorectal, lung, breast,prostatic carcinomaand leukemia.
 
Here's one I got from Jodi a while back...

Journal of International Medical Research Features Study on Body Fat Impact of Conjugated Linoleic Acid (CLA); Fifth Study in 18 months Confirms Body Fat Activity of CLA in Humans.
Author/s:
Issue: Jan 23, 2002

VERNON HILLS, Ill. -- A recent article published in The Journal of International Medical Research (JIMR) (2001:29:392-396) features a study presented by Scandinavian Clinical Research AS (SCR), of Kjeller, Norway, demonstrating that conjugated linoleic acid (CLA) reduces body fat in humans. This is the fifth peer-reviewed article addressing CLA's body fat reduction properties to be published in refereed medical journals over the last one and a half years.

"Body fat, measured using near infrared light, was significantly reduced in the group taking CLA during the study," said Dr. Ola Gudmundsen, PhD, CEO of Scandinavian Clinical Research, and a co-author of the study. "This study shows those participants who ingested 1.8 grams of CLA per day experienced body fat reduction versus the placebo group. These results confirm a trend seen in several recent CLA studies and suggest the need for the continued study of CLA and its impact on humans."

Conjugated linoleic acid is the common name of a group of fatty acids found in the past in dairy products and meat. Over the last 50 years, changes in livestock development practices have largely removed naturally occurring CLA from our diets. However, in several recent studies, CLA has received considerable attention due to its apparent metabolic and chemoprotective properties in animals, as well as some similar, initial results in humans. The effects include reduced body fat content, improved serum lipid profiles, decreased aortic lipid deposition, and enhanced glucose metabolism.

"This recently published study in the JIMR on the properties of CLA continues to demonstrate that CLA prevents fat from being deposited into the body," said Dr. Delbert Dorscheid, MD, PhD, University of British Columbia. "As it reduces body fat, it increases lean tissue. This action indirectly boosts a human's metabolism as lean tissue burns more calories than fatty tissue."

Dr. Gudmundsen further indicated that while the observations recorded in the Scandinavian Clinical Research report are in accordance with other recent CLA study results, the effect obtained in this Norwegian work is much more pronounced than that previously reported.

The study utilized 20 volunteers, aged 18 to 30 years, and utilized a randomized, double blind approach with two concurrently observed parallel groups. Participants were recruited from a physical fitness center where they participated in regular physical training consisting of 90 minutes of strenuous exercise, three times a week. Volunteers were directed not to change their diet or lifestyle during the study. The study was conducted according to the current Declaration of Helsinki, Good Clinical Practice and local health regulations.

Previously, a University of Wisconsin study concluded that subjects that stopped dieting and exercising regained less fat and retained more muscle mass when taking CLA versus those who had not. Another study published in The Journal of Nutrition found that without change in exercise or eating habits, an average reduction of six pounds of body fat occurred in subjects taking CLA, compared to a placebo group. Last year, a study that appeared in The International Journal of Obesity (Volume 25, Issue 8, August 2001) showed that male subjects classified as abdominally obese lost an average of one inch from their waistlines in a four-week period, when using CLA. Finally, a study that was published in Lipids (August 2001) found that of 53 patients, those taking CLA over the course of a 14 week trial experienced body fat reductions of 3.8 percent.

The CLA used in these studies was Tonalin(R), manufactured by Natural, Inc. Additional human studies on the body fat reduction aspects of CLA are underway and anticipated in the next year.

American Chemical Society, August 20, 2000 http://chemistry.org/portal/Chemistry?PID=acsdisplay.html&DOC=daily\sunday%5 Cweight.html

The Journal of Nutrition (Volume 130, #12, 2000) http://www.nutrition.org/cgi/content/abstract/130/12/2943?maxtoshow=&HITS=10&h its=10&RESULTFORMAT=&titleabstract=Conjugated+Linoleic+Acid&searchid=101121636 7276_11256&stored_search=&FIRSTINDEX=0&journalcode=nutrition

International Journal of Obesity (Volume 25, Issue 8, August 2001) http://content.naturesj.com/content/templates/el/el_searchexpand.htm?comm=0307 0565&token=000DCFA57D2110151D14D03A0AA59B&action=expand&caller=portal0&identif ier=npg%2f03070565%2f2001%2f00000025%2f00000008%2f0801659%2fpdf+npg%2f03070565 %2f2001%2f00000025%2f00000008%2f0801659&type=infobike&local=yes&format=applica tion

Lipids (Volume 36, Number 8, August 2001) http://www.aocs.org/press/jabs.asp?abs_id=2143&mo=8&yr=2001
 
Back
Top